Submission of intimation of Trading window Closure.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Astal Laboratories has informed the BSE that the trading window for its securities will be closed from 1st January 2026 until 48 hours after the company declares its unaudited financial results for the quarter ended 31st December 2025. During this period, all Directors, Officers, Designated Persons, and their immediate relatives are prohibited from trading in the company's shares. The Board meeting date to approve the Q3 FY26 results will be announced separately. The filing is signed by the Company Secretary, Mahendra Kumar, and is made in compliance with SEBI's Insider Trading Regulations, 2015.
This is a routine regulatory filing with no direct impact on shareholders. The window closure is a standard compliance practice ahead of quarterly results and signals that Q3 FY26 earnings are expected soon, which could be a catalyst for near-term stock movement.